Weekly Clinical Updates

Co-infection of SARS‐CoV‐2 and Influenza A/B among Patients with COVID-19: A Systematic Review and Meta-analysis | Oseltamivir Reduces 30-Day Mortality in Older Adults with Influenza: A Pooled Analysis from the 2012-2019 Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)

Respiratory Syncytial Virus Vaccine Effectiveness among U.S. Veterans | Transcutaneous Vagus Nerve Stimulation Improves Long COVID Symptoms in a Female Cohort | Distinct Pro-inflammatory/Pro-angiogenetic Signatures Distinguish Children | Persistent Symptoms and Clinical Findings in Adults with Post-acute Sequelae of COVID-19 Syndrome | Impact of COVID-19 Pandemic on the Incidence and Prevalence of Postural Orthostatic Tachycardia Syndrome

Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial | Host-microbe Multiomic Profiling Identifies Distinct COVID-19 Immune Dysregulation in Solid Organ Transplant Recipients | Real‐world Effectiveness and Safety of Oral Azvudine versus Nirmatrelvir‒ritonavir (Paxlovid) in Hospitalized Patients with COVID-19: A Multicenter, Retrospective, Cohort Study

Antiviral Medications for Treatment of Nonsevere Influenza: A Systematic Review and Network Meta-Analysis | Symptom Evolution in Individuals with Ongoing Symptomatic COVID-19 and Post COVID-19 Syndrome After SARS-CoV-2 Vaccination versus Influenza Vaccination | Neurological Post-COVID Syndrome is Associated with Substantial Impairment of Verbal Short-term and Working Memory

Mpox Vaccination Hesitancy, Previous Immunization Coverage, and Vaccination Readiness in the African Region | Global Prevalence and Correlates of Mpox Vaccine Acceptance and Uptake | The Effect of Nirmatrelvir/ritonavir on Short- and Long-term Adverse Outcomes from COVID-19 | Epidemiological Insights into Chronic Urticaria, Vitiligo, Alopecia Areata, and Herpes Zoster following COVID-19 Infection | Impact of Extended-course Oral Nirmatrelvir/ritonavir in Established Long COVID

In-hospital Outcomes of Healthcare-associated Coronavirus Disease 2019 (Omicron) Versus Healthcare-associated Influenza: A Retrospective, Nationwide Cohort Study in Switzerland | Real Clinical Effectiveness of Molnupiravir Against 30-day Mortality Among 74, 41 SARS-CoV-2–Positive Patients: A Nationwide Cohort Study from the Czech Republic